|
Our decision support processes offer the opportunity to quickly acquire scientific data and to assess the delivery platform. These processes allow both partners to work together on simple conditions, and to evaluate the efficiency of a potential future partnership. The decision support processes are flexible, but are performed under the highest level of laboratory practices and confidentiality.
Our 141™ (1 week for 1 answer) evaluation process provides a first theoretical answer on the potentiality of your candidate molecule(s) to be properly released by our delivery platform. This evaluation, which only needs the signature of a standard CDA between you and MedinCell, is based on the physico-chemical characteristics of your molecule(s). MedinCell’s Chemistry platform provides you with a preliminary answer in one week . This evaluation process delivers a green light for the 441™ evaluation.
Our 441™ ( 4 weeks for 1 test) evaluation process provides the first experimental data on your candidates in just four weeks. The MedinCell’s chemistry platform will test releases in different in vitro conditions, with different formulation possibilities of entrapped candidates. This evaluation is based on a simple Services Agreement Contract (Exclusivity Contract in option), and it is performed under a MTA. After this step, the partner will be able to send the green light to start with the feasibility studies. |
|
